The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies
Sponsor: Memorial Sloan Kettering Cancer Center
This PHASE1 trial investigates Lymphoma and Metastatic Solid Tumor and is currently completed. Memorial Sloan Kettering Cancer Center leads this study, which shows 14 recorded versions since 2011 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Apr 2023 — Jul 2024 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Jul 2022 — Apr 2023 [monthly]
Active Not Recruiting PHASE1
-
Sep 2021 — Jul 2022 [monthly]
Active Not Recruiting PHASE1
▶ Show 9 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE1
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Sep 2019 — Sep 2020 [monthly]
Active Not Recruiting PHASE1
-
Nov 2018 — Sep 2019 [monthly]
Active Not Recruiting PHASE1
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE1
-
Jul 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Apr 2017 — Jul 2017 [monthly]
Recruiting PHASE1
-
Feb 2017 — Apr 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Memorial Sloan Kettering Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .